NICE approves cluster headaches device
A handheld device that delivers a small electric current has been recommended in draft guidance by NICE for the prevention and treatment of cluster headaches.
Cluster headaches are a rare but painful type of headache affecting around 100,000 people in the UK. The recommendation made in NICE’s draft medtech guidance highlights that using gammaCore in addition to standard care (sumatriptan, zolmitriptan and oxygen) could save the NHS £450 per patient in the first year compared to standard care alone.
The guidance says that because gammaCore is not effective in all patients with cluster headache, it should only be used following a three-month trial period where it has been shown to be effective in reducing symptoms.
Clinical experts suggest that around 25 per cent of people in the UK with cluster headache – around 25,000 – are likely to respond to treatment with gammaCore.
The device aims to modify pain signals by stimulating the vagus nerve through the skin of the neck and can be used to stop pain when the person feels a cluster headache beginning or daily to help prevent cluster headaches. The device is small and portable and, after brief training, is designed to be used anywhere that is convenient.
Learn how to identify and help customers manage heartburn and indigestion, from recommending the right products to ease symptoms, to self-care advice and identifying red flags for referral
Upgrade your contraceptive consultations by exploring the interactive pack to learn about a daily oral contraceptive pill
Record my learning outcomes
Inspiring stories related to health, fitness and the pursuit of wellbeing
More like this
Benzodiazepines prescribed more in deprived areas, study confirms
Researchers found prescribing rates were 45 per cent higher in the most deprived populations compared to the least.
1 Min Article
Diabetes screening costs in pharmacy similar to GPs
The economic analysis used data collected from 172 patients from six pharmacies in Leicester and 164 patients from six pharmacies in Surrey.
1 Min Article
OTC Omeprazole tablets 20mg: an opportunity for pharmacy
This module highlights a new opportunity to treat heartburn and reflux in the pharmacy with Omeprazole 20mg, which is newly available for customers to purchase OTC.
10 Min Module
Let's talk tech: Using technology to drive your business
This training offers insights into making the most of technology and the commercial opportunities this can offer your business.
8 Min Module
Advising customers of a unique formulation for a blocked and runny nose from colds
Understand the differences between topical medication for nasal symptoms of the common cold, and topical medication for ongoing nasal problems
25 Min Module
Treating acid reflux and heartburn in the pharmacy
Understand how omeprazole 20mg works to treat heartburn and acid reflux symptoms
2 Min Module